MRI assessment of pituitary iron accumulation by using pituitary-R2 in ?-thalassemia patients
dc.contributor.author | Bozdağ M. | |
dc.contributor.author | Bayraktaroğlu S. | |
dc.contributor.author | Aydınok Y. | |
dc.contributor.author | Çallı M.C. | |
dc.date.accessioned | 2021-05-03T20:48:02Z | |
dc.date.available | 2021-05-03T20:48:02Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Background: Patients with thalassemia major (TM) require repeated blood transfusions, which leads to accumulation of iron in a wide variety of tissues. Accumulation of iron in the pituitary gland can lead to irreversible hypogonadotropic hypogonadism (HH) in this group of patients. Purpose: To investigate the reliability of pituitary-R2 as a marker to estimate the extent of pituitary iron load by comparing the pituitary magnetic resonance imaging (MRI) findings with hepatic iron load and serum ferritin levels. Material and Methods: A total of 38 ?-TM patients were classified into HH (group A, n = 18) and non-HH (group B, n = 17) groups. A third group, group C, consisted of 17 healthy participants. Each participant underwent 1.5-T MRI examinations. Pituitary gland heights (PGH), pituitary-R2 values, and liver-R2 values were measured by using multi-echo spin-echo sequences. Results: Pituitary-R2 values were significantly higher in group A compared with group B (P < 0.05). A positive correlation was detected between the pituitary-R2 values and serum ferritin levels in TM patients (P < 0.01). A threshold value of 14.1 Hz for pituitary-R2 was found to give a high specificity and sensitivity in distinguishing the TM patients with HH from those with normal pituitary functions. PGH measurements were significantly lower in group A compared with group B (P < 0.05). Conclusion: MRI-assessed pituitary-R2 seems to be a reliable marker for differentiating the TM patients with normal pituitary function from those with secondary hypogonadism due to iron toxicity. © 2017, © The Foundation Acta Radiologica 2017. | en_US |
dc.identifier.doi | 10.1177/0284185117730099 | en_US |
dc.identifier.endpage | 739 | en_US |
dc.identifier.issn | 0284-1851 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 28882060 | en_US |
dc.identifier.scopus | 2-s2.0-85044310854 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 732 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0284185117730099 | |
dc.identifier.uri | https://hdl.handle.net/11454/70706 | |
dc.identifier.volume | 59 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | SAGE Publications Inc. | en_US |
dc.relation.ispartof | Acta Radiologica | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | hypogonadotropic hypogonadism | en_US |
dc.subject | iron load | en_US |
dc.subject | magnetic resonance imaging (MRI) | en_US |
dc.subject | pituitary gland | en_US |
dc.subject | ?-thalassemia | en_US |
dc.title | MRI assessment of pituitary iron accumulation by using pituitary-R2 in ?-thalassemia patients | en_US |
dc.type | Article | en_US |